Skip to main content
Log in

Transglutaminase activity is related to CAG repeat length in patients with Huntington’s disease

  • Original investigation
  • Published:
Human Genetics Aims and scope Submit manuscript

Abstract

Huntington’s disease (HD) is a neurodegenerative disorder associated with CAG repeat expansion. We measured transglutaminase (TGase) activity in lymphocytes from 35 HD patients and from healthy individuals to ascertain whether it was altered in this condition. TGase activity was above maximum control levels in 25% of HD patients; it was correlated with the age of the patient and inversely correlated with the CAG repeat length. These results suggest that: (1) HD could be biochemically heterogeneous, and (2) the length of the CAG repeat expansion/TGase ratio could be important in the manifestation of HD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Additional information

Received: 25 March 1996 / Revised: 23 June 1996

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cariello, L., de Cristofaro, T., Zanetti, L. et al. Transglutaminase activity is related to CAG repeat length in patients with Huntington’s disease. Hum Genet 98, 633–635 (1996). https://doi.org/10.1007/s004390050273

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s004390050273

Keywords

Navigation